Of note, associations between plasma NGAL and the risk of new-onset CKD were stronger in participants who smoked, in participants with below-median UAE, and in participants with a slightly reduced eGFR (60–89 mL/min/1.73 m2), which all demonstrated significant interactions. Here, LCN2 is linked to chronic kidney disease.